INMB (STOCKS)
INmune Bio Inc. Common stock
$1.280000
+0.040000 (+3.23%)
Prev close: $1.240000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- David J. Moss
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $34.16M
- Employees
- 13
- P/E (TTM)
- -0.73
- P/B (TTM)
- 1.68
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
7
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.20 | $-0.27 | +0.0652 | +24.59% |
|
Sep 2025 (Q3)
|
$-0.24 | $-0.33 | +0.0915 | +27.60% |
|
Jun 2025 (Q2)
|
$-1.05 | $-0.39 | -0.6607 | -169.71% |
|
Mar 2025 (Q1)
|
$-0.43 | $-0.48 | +0.0494 | +10.30% |